Cancer‑testis antigen (CTA) is a well‑accepted optimal target library for cancer diagnosis
and treatment. Most CTAs are located on the X chromosome and aggregate into large gene …

Cancer vaccines, including peptide-based vaccines, have been considered a key tool of
effective and protective cancer immunotherapy because of their capacity to provide long …

Cancer/testis (CT) antigens are protein antigens with normal expression restricted to adult
testicular germ cells, and yet are aberrantly activated and expressed in a proportion of …

Cancer/testis (CT) antigens are protein antigens with normal expression restricted to adult
testicular germ cells, and yet are aberrantly activated and expressed in a proportion of …

Cancer/testis (CT) antigens are a category of tumor antigens with normal expression
restricted to male germ cells in the testis but not in adult somatic tissues. In some cases, CT …

The identification of cancer testis (CT) antigens has been an important advance in
determining potential targets for cancer immunotherapy. Multiple previous studies have …

Cancer testis antigens (CTA) are a large family of tumor-associated antigens expressed in
human tumors of different histological origin, but not in normal tissues except for testis and …

Cancer-testis antigens are tumor antigens that their expression is almost limited to male
germ cells in the TESTIS. Some of CANCER-testis antigens are also expressed in the ovary …

Tumour-specific antigens have been an area of interest in cancer therapy since their
discovery in the middle of the 20th century. In the era of immune-based cancer therapeutics …

Cancer–testis (CT) genes have a restricted expression in normal tissues except testis and a
wide range of tumor types. Testis is an immune-privileged site as a result of a blood barrier …